The ISPOR 13th Annual International Meeting is Co-Sponsored by the International Society for Pharmacoeconomics & Outcomes Research and the Purdue University School of Pharmacy Division of Continuing Education
For pharmacists (CPE): The ISPOR 13th Annual International Meeting is co-sponsored by Purdue University School of Pharmacy and ISPOR. Attendees can earn up to 13.75 hours (1.375 CEUs) for attending plenary sessions, issues panels, workshops, and podium sessions at the ISPOR 13th Annual International Meeting, up to 4 hours (0.4 CEUs) for each half-day short course, and up to 7.5 hours (0.75 CEUs) for each full day short course. Purdue University School of Pharmacy is accredited by the Accreditation Council on Pharmacy Education as a provider of continuing pharmacy education. This is a continuing education activity of Purdue University School of Pharmacy, an equal access/equal opportunity university. To receive the 13.75 contact hours of continuing education credit, pharmacists must attend the entire program and complete all registration and evaluations at its conclusion.
For physicians (CME): This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education. Purdue University School of Pharmacy is accredited by the ACCME to provide continuing medical education for physicians. Purdue University School of Pharmacy designates this educational activity for a maximum of 13.75 Category I credits for attending plenary sessions, issues panels, workshops, and podium sessions at the ISPOR 13th Annual International Meeting, up to 4 Category I credits for each half-day short course, and up to 7.5 Category I credits for each full day short course, toward the AMA Physician’s Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity. This is a continuing education activity of Purdue University School of Pharmacy, an equal access/equal opportunity university.
Instructions: To receive continuing education credit, obtain the ISPOR 13th Annual International Meeting Continuing Education Attendance and Evaluation Booklet at the ISPOR registration desk (those who are pre-registered will receive their Evaluation Booklet in their registration packet). Complete the information requested and return the entire Continuing Education Attendance and Evaluation Booklet to the ISPOR registration desk at the end of the meeting or send to the ISPOR office within two weeks of the close of the meeting. Certificates of participation will be sent 6-8 weeks after receipt of Attendance and Evaluation Booklets to those who register and complete the program evaluation. The fee for this service is $50 USD.
SESSION |
MONDAY |
TUESDAY |
WEDNESDAY |
TOTAL CREDITS |
Plenary Sessions |
1.25 |
2.5 |
0 |
3.75 |
Issue Panels |
1 |
1 |
0 |
2 |
Workshops |
0 |
1 |
3 |
4 |
Podiums |
4 |
0 |
0 |
4 |
TOTAL CREDITS |
6.25 |
4.5 |
3 |
13.75 |
SHORT COURSE TITLE |
LEAD INSTRUCTOR |
CREDITS |
Pharmacoeconomics for Decision-Makers |
Lorne Basskin |
7.5 |
Bayesian Analysis – Overview & Applications |
Bryan Luce |
7.5 |
Retrospective Database Analysis |
William Crown |
7.5 |
Finding & Extracting Cost Data |
Clark Paramore |
4 |
Modeling: Structure & Design of a Model |
Marc Botteman |
4 |
Applications in Using Large Databases |
Diana Brixner |
4 |
Financial Impact / Cost of Illness |
Josephine Mauskopf |
4 |
CEA alongside Clinical Trials |
Scott Ramsey |
4 |
Advanced Quantitative Methods for QoL/PRO |
Bruce Crawford |
4 |
Elements of Pharmaceutical / Biotech Pricing |
Jack Mycka |
4 |
Propensity Scores & Comorbidity Risk Adjustment |
Fadia Shaya |
4 |
Bayesian Analysis – Advanced |
Bryan Luce |
4 |
Discrete Event Analysis for Economic Evaluations |
Jaime Caro |
4 |
Patient-Reported Outcomes: Item Response Theory |
Lori McLeod |
4 |
Case Studies in Pharmaceutical / Biotech Pricing |
Jack Mycka |
4 |
Statistical Considerations in Health Economic Evaluations |
Henry Glick |
4 |
Applications of Statistical Considerations in Health Economic Evaluations |
Henry Glick |
4 |
Patient Registries |
Chris Pashos |
4 |
Utility Measures |
F. Reed Johnson |
4 |
Outcomes Research for Medical Devices & Diagnostics |
Seema Sonnad |
4 |
Introduction to Risk/Benefit Management in Health Care |
Dennis Raisch |
4 |
Advanced Decision Modeling for Health Economic Evaluations |
Andrew Briggs |
4 |